These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28920300)

  • 1. Prevalence, risk factors and survival of lung cancer in the idiopathic pulmonary fibrosis.
    Lee KJ; Chung MP; Kim YW; Lee JH; Kim KS; Ryu JS; Lee HL; Park SW; Park CS; Uh ST; Lee YC; Park SJ; Kim KH; Jeon YJ; Choi WI; Park YB; Kim DS; Jeong SH; Lee JH; Park MS
    Thorac Cancer; 2012 May; 3(2):150-155. PubMed ID: 28920300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study.
    Yoo H; Jeong BH; Chung MJ; Lee KS; Kwon OJ; Chung MP
    BMC Pulm Med; 2019 Aug; 19(1):149. PubMed ID: 31412851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Impact of Emphysema Evaluated by High-Resolution Computed Tomography on Idiopathic Pulmonary Fibrosis Diagnosed by Surgical Lung Biopsy.
    Kohashi Y; Arai T; Sugimoto C; Tachibana K; Akira M; Kitaichi M; Hayashi S; Inoue Y
    Respiration; 2016; 92(4):220-228. PubMed ID: 27576553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced incidence of lung cancer in patients with idiopathic pulmonary fibrosis treated with pirfenidone.
    Miura Y; Saito T; Tanaka T; Takoi H; Yatagai Y; Inomata M; Nei T; Saito Y; Gemma A; Azuma A
    Respir Investig; 2018 Jan; 56(1):72-79. PubMed ID: 29325685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer in patients with idiopathic pulmonary fibrosis: clinical characteristics and impact on survival.
    Lee T; Park JY; Lee HY; Cho YJ; Yoon HI; Lee JH; Jheon S; Lee CT; Park JS
    Respir Med; 2014 Oct; 108(10):1549-55. PubMed ID: 25175479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after surgery for pathologic stage IA non-small cell lung cancer associated with idiopathic pulmonary fibrosis.
    Saito Y; Kawai Y; Takahashi N; Ikeya T; Murai K; Kawabata Y; Hoshi E
    Ann Thorac Surg; 2011 Nov; 92(5):1812-7. PubMed ID: 21944440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of malignant diseases in idiopathic pulmonary fibrosis.
    Lee HY; Cho J; Kwak N; Lee J; Park YS; Lee CH; Lee SM; Yoo CG; Kim YW; Choi SM
    Sci Rep; 2020 Oct; 10(1):18260. PubMed ID: 33106517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [
    Justet A; Laurent-Bellue A; Thabut G; Dieudonné A; Debray MP; Borie R; Aubier M; Lebtahi R; Crestani B
    Respir Res; 2017 Apr; 18(1):74. PubMed ID: 28449678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of lung cancer on survival of idiopathic pulmonary fibrosis.
    Tomassetti S; Gurioli C; Ryu JH; Decker PA; Ravaglia C; Tantalocco P; Buccioli M; Piciucchi S; Sverzellati N; Dubini A; Gavelli G; Chilosi M; Poletti V
    Chest; 2015 Jan; 147(1):157-164. PubMed ID: 25166895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.
    Kimura M; Taniguchi H; Kondoh Y; Kimura T; Kataoka K; Nishiyama O; Aso H; Sakamoto K; Hasegawa Y
    Respiration; 2013; 85(6):456-63. PubMed ID: 23257350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of radiological emphysema on lung function test in idiopathic pulmonary fibrosis.
    Bodlet A; Maury G; Jamart J; Dahlqvist C
    Respir Med; 2013 Nov; 107(11):1781-8. PubMed ID: 24051272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hypersensitivity pneumonitis or idiopathic pulmonary fibrosis? Diagnostic role of high resolution Computed Tomography (HRCT).
    Zompatori M; Calabrò E; Chetta A; Chiari G; Marangio E; Olivieri D
    Radiol Med; 2003 Sep; 106(3):135-46. PubMed ID: 14612834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
    Oda K; Yatera K; Fujino Y; Kido T; Hanaka T; Sennari K; Fushimi K; Matsuda S; Mukae H
    Respir Investig; 2018 Jan; 56(1):64-71. PubMed ID: 29325684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis.
    Kawasaki H; Nagai K; Yoshida J; Nishimura M; Nishiwaki Y
    J Surg Oncol; 2002 Sep; 81(1):33-7. PubMed ID: 12210025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
    Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
    Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation.
    Esposito DB; Lanes S; Donneyong M; Holick CN; Lasky JA; Lederer D; Nathan SD; O'Quinn S; Parker J; Tran TN
    Am J Respir Crit Care Med; 2015 Nov; 192(10):1200-7. PubMed ID: 26241562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).
    Iwata T; Yoshino I; Yoshida S; Ikeda N; Tsuboi M; Asato Y; Katakami N; Sakamoto K; Yamashita Y; Okami J; Mitsudomi T; Yamashita M; Yokouchi H; Okubo K; Okada M; Takenoyama M; Chida M; Tomii K; Matsuura M; Azuma A; Iwasawa T; Kuwano K; Sakai S; Hiroshima K; Fukuoka J; Yoshimura K; Tada H; Nakagawa K; Nakanishi Y;
    Respir Res; 2016 Jul; 17(1):90. PubMed ID: 27450274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress.
    Castria D; Refini RM; Bargagli E; Mezzasalma F; Pierli C; Rottoli P
    Int J Immunopathol Pharmacol; 2012; 25(3):681-9. PubMed ID: 23058018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer risk among patients with combined pulmonary fibrosis and emphysema.
    Kwak N; Park CM; Lee J; Park YS; Lee SM; Yim JJ; Yoo CG; Kim YW; Han SK; Lee CH
    Respir Med; 2014 Mar; 108(3):524-30. PubMed ID: 24462477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis.
    Reichmann WM; Yu YF; Macaulay D; Wu EQ; Nathan SD
    BMC Pulm Med; 2015 Dec; 15():167. PubMed ID: 26714746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.